By Naveen Athrappully | The Epoch Times
Over half of COVID-19 vaccine recipients in a recent study were found to be suffering from some form of health complications one year after taking the shots.
The study, published at ScienceDirect on Nov. 10, examined potential post-COVID-19 vaccination syndrome (PCVS) among vaccinated individuals and assessed their quality of life (QoL). The study was conducted among adults aged 18 and above from India who had received either Bharat Biotech’s COVAXIN or the AstraZeneca COVID-19 vaccines.
Among vaccine recipients, 52.8 percent of individuals were found to have at least 1 PCVS a month after primary vaccination. At 12 months, 64.6 percent reported at least 1 PCVS. Though the quality of life rose at six months following vaccination, it subsequently fell at 12 months.
The overall prevalence of PCVS among individuals vaccinated with AstraZeneca was 65.59 percent compared to COVAXIN’s 59.4 percent.
Among individuals who took booster shots, over eight out of ten reported at least one PCVS, which is far higher than the five in ten people from the unvaccinated group who reported a similar syndrome.
The prevalence of PCVS “was similar to long-term COVID; it declined over time and increased following booster immunization. Contrary to PCVS prevalence, QoL rises with time and falls after booster doses,” the study concluded.
“There was a statistically significant difference in the prevalence of PCVS and QoL between booster dose recipients and no booster dose recipients.” The study was conducted between September 2021 and May 2023.
The authors of the study pointed out that research on the effects of immunization and its effects on people with long-term COVID have caused “debate as they gave rise to varying outcomes.”
“Some evidence indicates a change in, an improvement in, a continuation of, or even a worsening of long-term COVID symptoms following vaccination. The ratio of change in antibody titers was noticeably larger in the group of people whose illnesses became worse.” Antibody titer is a lab test that measures the level of antibodies in a blood sample.
The study was funded by the Indian Council of Medical Research. The two authors of the study, Yogendra Shrestha and Rajesh Venkataraman, are from the Department of Pharmacy Practice, Sri Adichunchanagiri College of Pharmacy, India.
They reported “no financial or interpersonal conflicts” that may have affected the study results. The Epoch Times reached out to the authors for comment.
Post-Vaccine Health Issues
More new studies are giving further evidence linking COVID-19 shots with health complications.
A March 2023 review published in the National Library of Medicine analyzed 81 articles that confirmed cardiovascular complications in 17,636 individuals who had taken an mRNA shot. The articles also reported 284 deaths.
Out of the 17,636 individuals, 17,192 of them had taken Pfizer’s COVID-19 shot, while the remaining 444 received Moderna jabs.
“Thrombosis was frequently reported with any mRNA vaccine, followed by stroke, myocarditis, myocardial infarction, pulmonary embolism, and arrhythmia,” it said.
Thrombosis was found to be common among those who had taken the Pfizer vaccine. Stroke was common among Moderna vaccine recipients. While Pfizer reported 228 deaths, the Moderna group saw 56 deaths.
“The time between the vaccination dosage and the first symptom onset averaged 5.6 and 4.8 days with the mRNA-1273 (Moderna) vaccine and BNT162b2 (Pfizer).”
In a Nov. 11 Substack post, cardiologist Peter A. McCullough claimed that the study pointed to “a cardiovascular safety disaster.” He said that 50 or more deaths with a widely used, novel product usually “prompts a worldwide recall.”
“To have 284 well-described deaths as a result of cardiovascular and or thrombotic complications is a striking finding in the medical literature for products that are still on the market and promoted by public health agencies all over the world.”
A preprint study published this month at medRxiv found that the most common chronic symptoms among people who received a COVID-19 vaccine were excessive fatigue, brain fog, numbness, neuropathy, and exercise intolerance.
At least half the participants also reported dizziness, burning sensations, tinnitus, headache, insomnia, palpitations, and myalgia (muscle pain and aches). Study participants reported a median of 22 symptoms.
The study was funded by the U.S. National Institutes of Health (NIH) and the Howard Hughes Medical Institute Collaborative COVID-19 Initiative.
Concerns about the ill effects of COVID-19 vaccines have reached Congress. In a Nov. 13 hearing in Washington convened by Rep. Marjorie Taylor Greene (R-Ga.), Dr. Robert Malone testified that DNA fragments have been detected in the Pfizer vaccine.
Dr. Malone helped invent the mRNA technology used in the mRNA COVID-19 vaccines like the one from Pfizer. He revealed that the vaccine contains a DNA sequence called SV40 and that this information was not disclosed to at least a few regulators.
The presence of SV40 in the vaccine is a “proven genotoxicity risk,” he warned. Genotoxicity refers to the ability of harmful substances to damage the genetic information in cells.
He suggested that the unusual cancers that have been popping off since the rollout of the vaccines could be due to the presence of these DNA fragments.
“And by the way, these DNA fragments may also be shown to contribute to genetic anomalies in fetus[es], which is one of the most prominent causes of premature abortion,” he said.
Meanwhile, the U.S. Centers for Disease Control and Prevention (CDC) recommends the 2023-2024 updated COVID-19 vaccines from Pfizer, Moderna, and Novavax to children as young as six months old, insisting that these are necessary to “protect against serious illness from COVID-19.”
Even with vaccination, there is no guarantee that a person would avoid infection. U.S. government files recently obtained by The Epoch Times showed that more than 5 million COVID-19 infections in 2021 actually occurred among vaccinated individuals.